IDACIO 50 MG/ML SOL INJ SC CT 2 SER PREENC VD TRANS X 0,8 ML + 2 LEN
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004101670026 -
GGREM
509520120028107 -
Código de barras
7899498608163 -
Código de barras
7899498609184
O que a fonte publica
- Detentor do registro
- FRESENIUS KABI BRASIL LTDA
- Princípios ativos
- ADALIMUMABE
- Embalagem
- 50 MG/ML SOL INJ SC CT 2 SER PREENC VD TRANS X 0,8 ML + 2 LEN
- Tipo de produto
- Biológico
- Classe terapêutica
- L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "IDACIO 50 MG/ML SOL INJ SC CT 2 SER PREENC VD TRANS X 0,8 ML + 2 LEN",
"holder": "FRESENIUS KABI BRASIL LTDA",
"stripe": null,
"barcodes": [
"7899498608163",
"7899498609184"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "509520120028107",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "49.324.221/0001-04",
"priceRegime": "Regulado",
"productName": "IDACIO",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "50 MG/ML SOL INJ SC CT 2 SER PREENC VD TRANS X 0,8 ML + 2 LEN",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "3390.93",
"icms-12": "3853.33",
"icms-17": "4085.46",
"icms-18": "4135.28",
"icms-19": "4186.33",
"icms-20": "4238.66",
"icms-21": "4292.32",
"icms-22": "4347.35",
"icms-23": "4403.80",
"icms-17.5": "4110.22",
"icms-19.5": "4212.34",
"icms-20.5": "4265.32",
"icms-22.5": "4375.39",
"icms-12-alc": "3807.09",
"icms-17-alc": "4036.43",
"icms-18-alc": "4085.66",
"icms-19-alc": "4136.10",
"icms-20-alc": "4187.80",
"icms-21-alc": "4240.81",
"icms-22-alc": "4295.18",
"icms-23-alc": "4350.96",
"withoutTaxes": "3350.24",
"icms-17.5-alc": "4060.89",
"icms-19.5-alc": "4161.79",
"icms-20.5-alc": "4214.14",
"icms-22.5-alc": "4322.89"
},
"pisCofinsList": "Positiva",
"substanceText": "ADALIMUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "4674.04",
"icms-12": "5311.41",
"icms-17": "5631.38",
"icms-18": "5700.05",
"icms-19": "5770.42",
"icms-20": "5842.55",
"icms-21": "5916.52",
"icms-22": "5992.37",
"icms-23": "6070.18",
"icms-17.5": "5665.51",
"icms-19.5": "5806.27",
"icms-20.5": "5879.30",
"icms-22.5": "6031.02",
"icms-12-alc": "5263.08",
"icms-17-alc": "5580.13",
"icms-18-alc": "5648.19",
"icms-19-alc": "5717.92",
"icms-20-alc": "5789.39",
"icms-21-alc": "5862.67",
"icms-22-alc": "5937.83",
"icms-23-alc": "6014.95",
"withoutTaxes": "4631.51",
"icms-17.5-alc": "5613.94",
"icms-19.5-alc": "5753.43",
"icms-20.5-alc": "5825.80",
"icms-22.5-alc": "5976.14"
},
"invalidBarcodes": [],
"activeSubstances": [
"ADALIMUMABE"
],
"therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004101670026",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L4B",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:509520120028107"